End Price Gouging for Medications Act

Hozzl · 2025-06-10T15:03:05Z

Explore the details of Senate Bill 1753 End Price Gouging for Medications Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

6/10/2025, 3:03 PM

Summary of Bill S 1753

The bill "A bill to require the Secretary of Health and Human Services to establish reference prices for prescription drugs for purposes of Federal health programs, and for other purposes," designated as S. 1753 in the 119th Congress, was introduced on May 14, 2025. The bill aims to mandate the Secretary of Health and Human Services to set reference prices for prescription drugs in Federal health programs, along with addressing other purposes not specified in the provided context.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 1753

Bill S 1753 is currently in the status of Bill Introduced since May 14, 2025. Bill S 1753 was introduced during Congress 119 and was introduced to the Senate on May 14, 2025. Bill S 1753's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of May 14, 2025

Bipartisan Support of Bill S 1753

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 1753

Primary Policy Focus

Health

Alternate Title(s) of Bill S 1753

A bill to require the Secretary of Health and Human Services to establish reference prices for prescription drugs for purposes of Federal health programs, and for other purposes.